Publication | Open Access
Insights into idarubicin antimicrobial activity against methicillin-resistant <i>Staphylococcus aureus</i>
32
Citations
40
References
2020
Year
Idarubicin and its analogs have the potential to become a new class of antimicrobials for the treatment of MRSA-related infections.
| Year | Citations | |
|---|---|---|
Page 1
Page 1